tiprankstipranks
Oncimmune Holdings PLC (GB:ONC)
LSE:ONC

Oncimmune Holdings (ONC) Share Price & Analysis

2 Followers

ONC Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range13.00p - 45.00p
Previous Close18.55p
Volume79.50K
Average Volume (3M)75.21K
Market Cap
£13.75M
Enterprise Value22.97M
Total Cash (Recent Filing)£1.43M
Total Debt (Recent Filing)£10.64M
Price to Earnings (P/E)3.8
Beta1.30
Oct 31, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding74,142,147
10 Day Avg. Volume60,883
30 Day Avg. Volume75,213
Standard Deviation0.19
R-Squared0.00633
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.40
Price to Sales (P/S)3278.46
Price to Cash Flow (P/CF)-2.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

19.99%<0.01%0.00%80.01%
19.99% Insiders
0.00% Other Institutional Investors
80.01% Public Companies and
Individual Investors

ONC FAQ

What was Oncimmune Holdings PLC’s price range in the past 12 months?
Oncimmune Holdings PLC lowest share price was 13.00p and its highest was 45.00p in the past 12 months.
    What is Oncimmune Holdings PLC’s market cap?
    Currently, no data Available
    When is Oncimmune Holdings PLC’s upcoming earnings report date?
    Oncimmune Holdings PLC’s upcoming earnings report date is Oct 31, 2024 which is in 216 days.
      How were Oncimmune Holdings PLC’s earnings last quarter?
      Currently, no data Available
      Is Oncimmune Holdings PLC overvalued?
      According to Wall Street analysts Oncimmune Holdings PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Oncimmune Holdings PLC pay dividends?
        Oncimmune Holdings PLC does not currently pay dividends.
        What is Oncimmune Holdings PLC’s EPS estimate?
        Oncimmune Holdings PLC’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Oncimmune Holdings PLC have?
        Oncimmune Holdings PLC has 74,142,140 shares outstanding.
          What happened to Oncimmune Holdings PLC’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Oncimmune Holdings PLC?
          Currently, no hedge funds are holding shares in GB:ONC
          ---

          Oncimmune Holdings Stock Smart Score

          Company Description

          Oncimmune Holdings PLC

          Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes EarlyCDT and ImmunoINSIGHTS. It generates maximum revenue from the EarlyCDT segment.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Advanced Oncotherapy
          Genedrive
          SkinBioTherapeutics
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis